http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3878459-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bd7c0ee90e9a61b4c9d6ca5a253180ff
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-193
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1841
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1833
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2066
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2013
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-44
filingDate 2014-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c128c05dfbbb3e6c76e0ee4dd8c1561d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1892822cc910f7710082e6004f166af0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6797e6ad1408f179c89a364f9beac729
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f8a4b5b55d793a35cd632a8bfd9bcce
publicationDate 2021-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3878459-A1
titleOfInvention Use of allogeneic interstitial vessel layer cell and allogeneic mesenchymal progenitor cell for preventing or treating osteoarthritis
abstract Provided are uses of allogeneic interstitial vessel-layer cells and allogeneic mesenchymal progenitor cells in the preparation of a pharmaceutical composition for preventing or treating osteoarthritis (OA). Also provided is a pharmaceutical composition containing the allogeneic interstitial vessel-layer cells and the allogeneic mesenchymal progenitor cells.
priorityDate 2013-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013003899-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004166096-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012201791-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4946778-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012039961-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011262402-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012269774-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749

Total number of triples: 38.